Twist Bioscience Corp Goodwill & Intangibles Disclosure
| September 30, | ||||||||||||||
| (in thousands) | 2025 | 2024 | ||||||||||||
| Balance at beginning of year | $ | 85,811 | $ | 85,811 | ||||||||||
| Sale of business (see note 6) | (3,616) | — | ||||||||||||
| Balance at end of year | $ | 82,195 | $ | 85,811 | ||||||||||
| September 30, 2025 | ||||||||||||||||||||||||||
| (in thousands, except for years) | Weighted average Amortization period in years | Gross carrying amount | Accumulated amortization | Net book value | ||||||||||||||||||||||
| Developed Technology | 17 | $ | 17,900 | $ | (4,475) | $ | 13,425 | |||||||||||||||||||
| Total finite-lived intangible assets | $ | 17,900 | $ | (4,475) | $ | 13,425 | ||||||||||||||||||||
| September 30, 2024 | ||||||||||||||||||||||||||||||||
| (in thousands, except for years) | Weighted average Amortization period in years | Gross carrying amount | Impairment | Accumulated amortization | Net book value | |||||||||||||||||||||||||||
| Developed Technology | 17 | $ | 50,020 | $ | (25,198) | $ | (10,344) | $ | 14,478 | |||||||||||||||||||||||
| Customer Relationships | — | 15,210 | (10,541) | (4,669) | — | |||||||||||||||||||||||||||
| Tradenames & Trademarks | — | 900 | (125) | (775) | — | |||||||||||||||||||||||||||
| Total finite-lived intangible assets | $ | 66,130 | $ | (35,864) | $ | (15,788) | $ | 14,478 | ||||||||||||||||||||||||
Years ending September 30, | ||||||||
| 2026 | $ | 1,053 | ||||||
| 2027 | 1,053 | |||||||
| 2028 | 1,053 | |||||||
| 2029 | 1,053 | |||||||
| 2030 | 1,053 | |||||||
| Thereafter | 8,160 | |||||||
| $ | 13,425 | |||||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Nov 17, 2025 | Showing above |
| 2024 | Nov 18, 2024 | |
| 2023 | Nov 21, 2023 | |
| 2022 | Nov 28, 2022 | |
| 2021 | Nov 23, 2021 | |
| 2020 | Nov 27, 2020 | |
| 2019 | Dec 13, 2019 | |
About Goodwill & Intangibles Disclosures
Goodwill and intangible asset disclosures reveal the premium paid in acquisitions and how management assesses whether that premium retains its value. Since goodwill is no longer amortized under US GAAP, the annual impairment test is the only mechanism that adjusts carrying values downward — making the assumptions behind that test critically important for investors.
Key signals: a history of goodwill impairments suggests management consistently overpays for acquisitions. Watch the gap between reporting unit fair value and carrying amount — when fair value exceeds carrying amount by less than 10-20%, a small decline in business performance could trigger a write-down. For finite-lived intangibles, examine useful life assumptions across customer relationships, technology, and trade names; aggressive estimates inflate near-term earnings. Compare total intangibles-to-total-assets ratios against peers to assess acquisition dependency. Rising goodwill as a percentage of equity can signal balance sheet fragility.